PHARMACYTE BIOTECH, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2017 | -54.9% | -54.9% | -51.3% |
| FY2018 | -118.4% | -118.4% | -106.5% |
| FY2019 | -80.7% | -80.7% | -70.3% |
| FY2020 | -75.2% | -75.2% | -62.1% |
| FY2021 | -53.2% | -53.2% | -48.0% |
| FY2022 | -4.7% | -4.7% | -4.7% |
| FY2023 | -5.9% | -5.9% | -5.9% |
| FY2024 | 1.2% | 1.2% | 0.6% |
| FY2025 | 59.1% | 59.1% | 55.6% |
| FY2026 | -58.3% | -58.3% | -41.5% |